These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 9925750

  • 1. Protein kinase calpha is an effector of hexamethylene bisacetamide-induced differentiation of Friend erythroleukemia cells.
    Mallia CM, Aguirre V, McGary E, Tang Y, Scandurro AB, Liu C, Noguchi CT, Beckman BS.
    Exp Cell Res; 1999 Feb 01; 246(2):348-54. PubMed ID: 9925750
    [Abstract] [Full Text] [Related]

  • 2. Nuclear protein kinase C activity is decreased in Friend erythroleukemia cells induced to differentiate.
    Beckman BS.
    Exp Hematol; 1992 Mar 01; 20(3):324-7. PubMed ID: 1568447
    [Abstract] [Full Text] [Related]

  • 3. Inhibition by bryostatin 1 of the phorbol ester-induced blockage of differentiation in hexamethylene bisacetamide-treated Friend erythroleukemia cells.
    Dell'Aquila ML, Nguyen HT, Herald CL, Pettit GR, Blumberg PM.
    Cancer Res; 1987 Nov 15; 47(22):6006-9. PubMed ID: 3478136
    [Abstract] [Full Text] [Related]

  • 4. Nuclear but not cytoplasmic phospholipase C beta 1 inhibits differentiation of erythroleukemia cells.
    Matteucci A, Faenza I, Gilmour RS, Manzoli L, Billi AM, Peruzzi D, Bavelloni A, Rhee SG, Cocco L.
    Cancer Res; 1998 Nov 15; 58(22):5057-60. PubMed ID: 9823310
    [Abstract] [Full Text] [Related]

  • 5. Erythroid potentiating activity of tissue inhibitor of metalloproteinases on the differentiation of erythropoietin-responsive mouse erythroleukemia cell line, ELM-I-1-3, is closely related to its cell growth potentiating activity.
    Murate T, Yamashita K, Ohashi H, Kagami Y, Tsushita K, Kinoshita T, Hotta T, Saito H, Yoshida S, Mori KJ.
    Exp Hematol; 1993 Jan 15; 21(1):169-76. PubMed ID: 8417953
    [Abstract] [Full Text] [Related]

  • 6. Hexamethylene bisacetamide-induced differentiation of Friend virus-transformed murine erythroleukemia cells is associated with parallel changes in casein kinase II and guanine nucleotide exchange factor activities.
    Aroor AR, Singh LP, Wahba AJ.
    Exp Hematol; 1995 Oct 15; 23(11):1204-11. PubMed ID: 7556531
    [Abstract] [Full Text] [Related]

  • 7. Hexamethylene bisacetamide-induced differentiation of transformed cells: molecular and cellular effects and therapeutic application.
    Marks PA, Rifkind RA.
    Int J Cell Cloning; 1988 Jul 15; 6(4):230-40. PubMed ID: 3047266
    [Abstract] [Full Text] [Related]

  • 8. Polyamine biosynthesis enzymes in the induction and inhibition of differentiation in Friend erythroleukemia cells.
    Gazitt Y, Friend C.
    Cancer Res; 1980 May 15; 40(5):1727-32. PubMed ID: 6154532
    [Abstract] [Full Text] [Related]

  • 9. Nitric oxide-releasing agents and cGMP analogues inhibit murine erythroleukemia cell differentiation and suppress erythroid-specific gene expression: correlation with decreased DNA binding of NF-E2 and altered c-myb mRNA expression.
    Suhasini M, Boss GR, Pascual FE, Pilz RB.
    Cell Growth Differ; 1995 Dec 15; 6(12):1559-66. PubMed ID: 9019161
    [Abstract] [Full Text] [Related]

  • 10. Effect of hexamethylene bisacetamide on the commitment to differentiation of murine erythroleukemia cells.
    Fibach E, Reuben RC, Rifkind RA, Marks PA.
    Cancer Res; 1977 Feb 15; 37(2):440-4. PubMed ID: 264411
    [Abstract] [Full Text] [Related]

  • 11. Alterations in electrophoretic mobility, diaphorase activity, and terminal differentiation induced in murine erythroleukemia lines by differentiating agents.
    Gascoyne PR, Becker FF.
    J Cell Physiol; 1990 Feb 15; 142(2):309-15. PubMed ID: 2303526
    [Abstract] [Full Text] [Related]

  • 12. Commitment to erythroid differentiation in mouse erythroleukemia cells is controlled by alterations in topoisomerase II alpha phosphorylation.
    Constantinou AI, Vaughan AT, Yamasaki H, Kamath N.
    Cancer Res; 1996 Sep 15; 56(18):4192-9. PubMed ID: 8797591
    [Abstract] [Full Text] [Related]

  • 13. Phorbol ester tumor promoters block the transition from the early to the heme-dependent late program of Friend cell differentiation.
    Mager D, Bernstein A.
    J Cell Physiol; 1980 Dec 15; 105(3):519-26. PubMed ID: 6936401
    [Abstract] [Full Text] [Related]

  • 14. Induction of a novel nuclear protein (p54) by phorbol esters in mouse erythroleukemia (Friend) cells.
    Mitsuse S, Oishi M.
    Cancer Res; 1985 Aug 15; 45(8):3836-42. PubMed ID: 3860288
    [Abstract] [Full Text] [Related]

  • 15. Proteomic analysis of erythroid differentiation induced by hexamethylene bisacetamide in murine erythroleukemia cells.
    Petrak J, Myslivcova D, Man P, Cmejlova J, Cmejla R, Vyoral D.
    Exp Hematol; 2007 Feb 15; 35(2):193-202. PubMed ID: 17258068
    [Abstract] [Full Text] [Related]

  • 16. Changes in CuZn-superoxide dismutase during induced differentiation of murine erythroleukemia cells.
    Paoletti F, Mocali A.
    Cancer Res; 1988 Dec 01; 48(23):6674-7. PubMed ID: 3180077
    [Abstract] [Full Text] [Related]

  • 17. The subcellular distribution of protein kinase Calpha, -epsilon, and -zeta isoforms during cardiac cell differentiation.
    Xu FY, Fandrich RR, Nemer M, Kardami E, Hatch GM.
    Arch Biochem Biophys; 1999 Jul 01; 367(1):17-25. PubMed ID: 10375394
    [Abstract] [Full Text] [Related]

  • 18. Continuous suppression of globin gene expression and differentiation of Friend erythroleukemia cells by phorbol 12-myristate 13-acetate (PMA) despite the loss of PMA binding sites by down regulation.
    Yamasaki H, Martel N, Fusco A, Ostertag W.
    Proc Natl Acad Sci U S A; 1984 Apr 01; 81(7):2075-9. PubMed ID: 6326103
    [Abstract] [Full Text] [Related]

  • 19. Evidence that a novel human differentiation-inhibiting protein blocks the dimethyl sulfoxide-induced differentiation of erythroleukemia cells by inhibiting the activation of membrane protein kinase C.
    Durkin JP, Chakravarthy B, Tremblay R, Jouishomme H, Whitfield JF, Biquard JM, Krsmanovic V.
    Cancer Res; 1992 Nov 15; 52(22):6329-34. PubMed ID: 1423278
    [Abstract] [Full Text] [Related]

  • 20. A Myb dependent pathway maintains Friend murine erythroleukemia cells in an immature and proliferating state.
    Chen J, Kremer CS, Bender TP.
    Oncogene; 2002 Mar 14; 21(12):1859-69. PubMed ID: 11896618
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.